The reversal of the inhibition on lipids synthesis by L-659,699 in arterial smooth muscle cells cultures

Molecular and Cellular Biochemistry

Volumn 221, Issue 1-2, 2001, Pages 25-31

  Carazo, Angel ^a   Alejandre, Maria José ^a   Louktibi, Abdelaaziz ^a   Linares, Ana ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

HMG CoA synthase inhibitor; Smooth muscle cells cholesterol; Triacylglycerides

Indexed keywords

FUSARIUM SP.;

12 HYDROXY 13 HYDROXYMETHYL 3,5,7 TRIMETHYLTETRADECA 2,4 DIENEDIOIC ACID 12,14 LACTONE; CHOLESTEROL; CHOLESTEROL ESTER; ENZYME INHIBITOR; HMG-COA SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LACTONE; LIPID; LONG CHAIN FATTY ACID COENZYME A LIGASE; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ANIMAL; ARTERY; ARTICLE; ATHEROGENIC DIET; BIOSYNTHESIS; CELL CULTURE; CHICKEN; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; KINETICS; MALE; METABOLISM; NEWBORN; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANIMALS, NEWBORN; ARTERIES; CELLS, CULTURED; CHICKENS; CHOLESTEROL; CHOLESTEROL ESTERS; COENZYME A LIGASES; DIET, ATHEROGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FATTY ACIDS, UNSATURATED; HYDROXYMETHYLGLUTARYL-COA SYNTHASE; KINETICS; LACTONES; LIPIDS; MALE; MUSCLE, SMOOTH, VASCULAR; TRIGLYCERIDES;

EID: 0035348277     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010913621768     Document Type: Article

References (35)

1. Ross R: The pathogenesis of atherosclerosis - a perspective for the 90s. Nature 362: 801-809, 1993
2. Balls JU, Haust MD, More RH: Electron microscopic studies in human atherosclerosis: Cellular elements in fatty streaks. Exp Mol Pathol 3: 511-525, 1964
3. Geer JC: Fine structure of human aortic intimal thickening and fatty streaks. Lab Invest 14: 1764-1783, 1965
4. Geer JC, McGilIl HC Jr, Strong JP: The fine structure of human atherosclerotic lesions. Am J Pathol 38: 263-287, 1961
5. Ghidoni JJ, O'Neal RM: Recent advances in molecular pathology. A review: Ultrastructure of human atheromas. Exp Mol Pathol 7: 378-406, 1967
6. Haust MD: Atherosclerosis and smooth muscle cells. In: N.L. Stephens (ed). Biochemistry of Smooth Muscle Cells, vol II. CRC Press, Boca Raton, 1983, pp 183-250
7. Ross R, Glomset JA: Atherosclerosis and the arterial smooth muscle cells. Science 180: 1332-1339, 1973
8. Ross R, Glomset JA: The pathogenesis of atherosclerosis. N Engl J Med 295: 369-377 and 420-425, 1976
9. Ross R: The pathogenesis of atherosclerosis-an update. N Engl J Med 314: 488-500, 1986
10. Schwart SM, Campbell GR, Campbell JH: Replication of smooth muscle cells in vascular disease. Circ Res 58: 427-444, 1986
11. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52: 223-261, 1983
12. Brown SM, Goldstein JL: Scavenging for receptors. Nature 343: 508-509, 1990
13. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924, 1989
14. Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease. New perspective based on Framingham study. Ann Intern Med 90: 85-91, 1979
15. Habenicht AJR, Glomset JA, Ross R: Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 373 cells stimulated to divide by platelet derived growth factor. J Biol Chem 255: 5134-5140, 1980
16. Doyle JW, Kandutsch AA: Requirement for mevalonate in cycling cells: Quantitative and temporal aspects. J Cell Physiol 137: 133-140, 1988
17. Waters D, Higginson L, Gladstone P, Kimball B, Le-May M, Boccuzzi SI, Lesperance J: Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Atherosclerosis Intervention Trial. Circulation 89: 959-968, 1994
18. Riessen R, Axel DI, Fenchel M, Herzog UU, Rossman H, Karsch KR: Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells. Basic Res Cardiol 94: 322-332, 1999
19. Kitahara M, Karaki T, Toyoda K, Miyakashi C, Tanaka S, Tamaki T, Saito Y: NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery. Jpn J Pharmacol 77: 117-128, 1998
20. Bergstrom JF, Wong GA, Edwards PA, Edmond J: The regulation of acetoacetyl-CoA synthetase activity by modulators of cholesterol synthesis in vivo and the utilization of acetoacetate for cholesterogenesis. J Biol Chem 229: 14548-14553, 1984
21. Li AC, Tanaka RD, Callaway K, Fogelman AM, Edwards A: Localization of 3-hydroxy-3-methylglutaryl CoA reductase and 3-hydroxy3-3-methylglutaryl CoA synthase in the rat liver and intestine is affected by cholestyramine and mevinolin. J Lipid Res 29: 781-796, 1988
22. Chang TY, Limanek JS: Regulation of cytosolic acetoacetyl coenzyme A thiolase, 3-hydroxy-3-methylglutaryl coenzyme A synthase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and mevalonate kinase by low density lipoprotein and by 25-hydroxycholesterol in Chinese hamster ovary cells. J Biol Chem 255: 5452-5456, 1980
23. Maltese WA, Reitz BA, Volpe JJ: Effects of isoleucine deprivation on synthesis of sterol and fatty acids in LM-cells. J Biol Chem 256: 2185-2193, 1981
24. Greenspan MD, Yudkovitz JB, Lo ChL, Chen J, Alberts AW, Hunt VM, Chang MN, Yang SS, Thompson KL, Chiang YP, Chabala JC, Monaghan RL, Schwarte KL: Inhibition ofhydroxymethylglutaryl-coenzyme A synthase by L-659,699. Proc Nat Acad Sci USA 84: 7488-7492, 1987
25. Carazo A, Alejandre MJ, Diaz R, Rios A, Castillo M, Linares A: Changes in cultured arterial smooth muscle cells isolated from chicks upon cholesterol feeding. Lipids 33: 181-190, 1998
26. Blaes N, Bourdillon MC, Daniel-Lamaziere JM, Millaelle JJ, Andujar M, Covacho C: Isolation of two morphologically distinct cell lines from rat arterial smooth muscle expressing high tumorigenic potentials. In Vitro Cell Dev Biol 27: 725-734, 1991
27. Ross R: The smooth muscle cells II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50: 172-186, 1971
28. Chamley-Campbell JH, Campbell GR, Ross R: The smooth muscle in culture. Physiol Rev 58: 1-61, 1979
29. Poumay Y, Ronveaux-Dupal MF: Rapid preparative isolation of concentrated low density lipoproteins and of lipoprotein-deficient serum using vertical rotor gradient J Lipids Res 26: 1476-1480, 1985
30. Brown MS, Ho YK, Golstein JL: The cholesterol ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesterol esters. J Biol Chem 255: 9344-9352, 1980
31. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254, 1976
32. Duserre E, Bourdillon MC, Clavatti M, Covacho Ch, Renaud S: Lipids biosynthesis in cultured arterial smooth muscle cells is related to their phenotype. Lipids 28: 589-592, 1993
33. Dartsch PC, Ischinger T, Betz E: Differential effect of phofrin II on growth of human smooth muscle cells from nonatherosclerotic arteries and atheromatous plaques in vitro. Atherosclerosis 10: 616-624, 1990
34. Pickering JG, Weir L, Rosenfeld K, Stetz J, Jikanowski J, Isner JM: Smooth muscle cells outgrowth from human atherosclerotic plaque. Implications for the assessment of lesion biology. J Am Col Cardiol 20: 430-439, 1992
35. Edwars IJ, Wagner WD: Distinct synthetic and structural characteristic of proteoglycans produced by cultured artery smooth cells of arther-osclerotis-susceptible pigeons, J Biol Chem 263: 9612-9620, 1988